Analysen zu Novo Nordisk
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
| 07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 05.02.26 | Elmos Semiconductor Buy | Warburg Research | |
| 05.02.26 | Heidelberger Druckmaschinen Hold | Warburg Research | |
| 05.02.26 | RATIONAL Buy | Warburg Research | |
| 05.02.26 | OMV Underweight | Barclays Capital | |
| 05.02.26 | GSK Hold | Deutsche Bank AG | |
| 05.02.26 | Vodafone Group Buy | Deutsche Bank AG | |
| 05.02.26 | UBS Buy | Deutsche Bank AG | |
| 05.02.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.26 | Novartis Buy | Deutsche Bank AG | |
| 05.02.26 | BAT Buy | Deutsche Bank AG | |
| 05.02.26 | ATOSS Software Buy | Deutsche Bank AG | |
| 05.02.26 | Delivery Hero Hold | Deutsche Bank AG | |
| 05.02.26 | Sartorius vz. Buy | Deutsche Bank AG | |
| 05.02.26 | Salzgitter Buy | Deutsche Bank AG | |
| 05.02.26 | PVA TePla Buy | Deutsche Bank AG | |
| 05.02.26 | Infineon Buy | Deutsche Bank AG | |
| 05.02.26 | BNP Paribas Hold | Deutsche Bank AG | |
| 05.02.26 | Alphabet A Overweight | Barclays Capital | |
| 05.02.26 | BBVA Sector Perform | RBC Capital Markets | |
| 05.02.26 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 05.02.26 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | L'Oréal Buy | UBS AG | |
| 05.02.26 | Symrise Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Vonovia Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | QIAGEN Buy | Jefferies & Company Inc. | |
| 05.02.26 | Alphabet A Buy | Jefferies & Company Inc. | |
| 05.02.26 | Novo Nordisk Neutral | UBS AG | |
| 05.02.26 | Alphabet A Outperform | RBC Capital Markets | |
| 05.02.26 | Infineon Buy | UBS AG | |
| 05.02.26 | E.ON Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Infineon Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | GEA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | RWE Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | Rheinmetall Buy | Jefferies & Company Inc. | |
| 04.02.26 | BP Sector Perform | RBC Capital Markets | |
| 04.02.26 | Alstom Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | BASF Underweight | JP Morgan Chase & Co. | |
| 04.02.26 | Philips Overweight | Barclays Capital | |
| 04.02.26 | Siemens Healthineers Overweight | Barclays Capital | |
| 04.02.26 | FedEx Buy | UBS AG | |
| 04.02.26 | Givaudan Halten | DZ BANK | |
| 04.02.26 | Infineon Kaufen | DZ BANK | |
| 04.02.26 | SAP Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 04.02.26 | Michelin Outperform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.